Verma N, Pan H, Doré LC, Shukla A, Li QV, Pelham-Webb B, Teijeiro V, González F, Krivtsov A, Chang C-J et al..  2018.  TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells.. Nat Genet. 50(1):83-95.

Gabel HW, Kinde B, Stroud H, Gilbert CS, Harmin DA, Kastan NR, Hemberg M, Ebert DH, Greenberg ME.  2015.  Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.. Nature. 522(7554):89-93.

Thomas AA, Fisher JL, Rahme GJ, Hampton TH, Baron U, Olek S, Schwachula T, C Rhodes H, Gui J, Tafe LJ et al..  2015.  Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.. Neuro Oncol. 17(6):801-9.

Lesch BJ, Page DC.  2014.  Poised chromatin in the mammalian germ line.. Development. 141(19):3619-26.

Chung YRock, Schatoff E, Abdel-Wahab O.  2012.  Epigenetic alterations in hematopoietic malignancies.. Int J Hematol. 96(4):413-27.

Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J et al..  2007.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.. Cancer Cell. 11(2):147-60.